Insmed (INSM) Amortizatization of Intangibles (2013 - 2026)

Insmed's (INSM) quarterly Amortizatization of Intangibles came in at $678000.0 in Q1 2026, little changed year-on-year from $678000.0 in Q1 2025, and little changed quarter-over-quarter from $678000.0 in Q4 2025.

Insmed (INSM) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends

Insmed's Amortizatization of Intangibles history runs 14 years deep, the most recent figure standing at $678000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles changed 0.0% year-over-year to $678000.0 in Q1 2026; TTM through Mar 2026 was $2.7 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2.7 million, changed 0.0% from the prior year.
  • Amortizatization of Intangibles was little changed at $678000.0 in Q1 2026 per INSM's latest filing, from $678000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $729000.0 in Q1 2022 and bottomed at $114000.0 in Q4 2022.
  • The 5-year median for Amortizatization of Intangibles is $678000.0 (2023), against an average of $633764.7.
  • Across the five-year window, Amortizatization of Intangibles slumped 99.6% in 2022 and jumped 494.74% in 2023, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $114000.0 in 2022, then soared by 494.74% to $678000.0 in 2023, then changed by 0.0% to $678000.0 in 2024, then changed by 0.0% to $678000.0 in 2025, then changed by 0.0% to $678000.0 in 2026.
  • Per Business Quant, the three latest INSM Amortizatization of Intangibles figures stand at $678000.0 (Q1 2026), $678000.0 (Q4 2025), and $678000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Insmed 22.60 Bn 21.38 Bn 258.54 Mn 678,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 678,000.00
Mar 31, 2026 678,000.00
Dec 31, 2025 678,000.00
Dec 31, 2025 678,000.00
Sep 30, 2025 678,000.00
Sep 30, 2025 678,000.00
Jun 30, 2025 678,000.00
Jun 30, 2025 678,000.00
Mar 31, 2025 678,000.00
Mar 31, 2025 678,000.00
Dec 31, 2024 678,000.00
Dec 31, 2024 678,000.00
Sep 30, 2024 678,000.00
Sep 30, 2024 678,000.00
Jun 30, 2024 678,000.00
Jun 30, 2024 678,000.00
Mar 31, 2024 678,000.00
Mar 31, 2024 678,000.00
Dec 31, 2023 678,000.00
Dec 31, 2023 678,000.00